2-deoxy-2-acetamido-beta-D-galactose-4-sulfate

Identification

Generic Name: 2-deoxy-2-acetamido-beta-D-galactose-4-sulfate
DrugBank Accession Number: DB01872
Background: Not Available
Type: Small Molecule
Groups: Experimental
Structure: 3D
MOL SDF 3D-SDF PDB SMILES InChI
Similar Structures
Structure for 2-deoxy-2-acetamido-beta-D-galactose-4-sulfate (DB01872)
Synonyms: Not Available

Pharmacology

Indication

Not Available

Pharmacology

Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:

Machine Learning

Accelerate your drug discovery research with our fully connected ADMET dataset

Contraindications & Blackbox Warnings

Contraindications

Contraindications & Blackbox Warnings

With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.

Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects

Pharmacodynamics

Not Available

Mechanism of action

Target	Actions	Organism
UChondroitinase (Chondroitin lyase)	Not Available	Arthrobacter aurescens
UChondroitinase-B	Not Available	Pedobacter heparinus (strain ATCC 13125 / DSM 2366 / NCIB 9290)
UHyaluronate lyase	Not Available	Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)
UChondroitinase-AC	Not Available	Pedobacter heparinus (strain ATCC 13125 / DSM 2366 / NCIB 9290)

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Not Available

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects

Medicalerrors

Reduce medical errors

and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.

Reduce medical errors & improve treatment outcomes with our adverse effects data

Toxicity

Not Available

Pathways

Not Available

Pharmacogenomic Effects/ADRs

Not Available

Interactions

Drug Interactions: This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions: Not Available

Categories

Drug Categories

Not Available

Chemical TaxonomyProvided by Classyfire

Description: This compound belongs to the class of organic compounds known as acylaminosugars. These are organic compounds containing a sugar linked to a chain through N-acyl group.
Kingdom: Organic compounds
Super Class: Organic oxygen compounds
Class: Organooxygen compounds
Sub Class: Carbohydrates and carbohydrate conjugates
Direct Parent: Acylaminosugars
Alternative Parents: N-acyl-alpha-hexosamines / Hexoses / Monosaccharide sulfates / Alkyl sulfates / Sulfuric acid monoesters / Oxanes / Acetamides / Secondary alcohols / Secondary carboxylic acid amides / Hemiacetals
show 7 more
Substituents: Acetamide / Acylaminosugar / Alcohol / Aliphatic heteromonocyclic compound / Alkyl sulfate / Carbonyl group / Carboxamide group / Carboxylic acid derivative / Hemiacetal / Hexose monosaccharide
show 18 more
Molecular Framework: Aliphatic heteromonocyclic compounds
External Descriptors: Not Available

Affected organisms

Not Available

Chemical Identifiers

UNII: Not Available
CAS number: Not Available
InChI Key: WHCJUIFHMJFEFZ-UIAUGNHASA-N
InChI: InChI=1S/C8H15NO9S/c1-3(11)9-5-6(12)7(18-19(14,15)16)4(2-10)17-8(5)13/h4-8,10,12-13H,2H2,1H3,(H,9,11)(H,14,15,16)/t4-,5-,6-,7+,8-/m1/s1
IUPAC Name: [(2R,3R,4R,5R,6R)-5-acetamido-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxidanesulfonic acid
SMILES: CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS(O)(=O)=O)[C@@H]1O

References

General References

Not Available

External Links

Human Metabolome Database: HMDB0000781
PubChem Compound: 446101
PubChem Substance: 46508675
ChemSpider: 393546
ChEBI: 44391
ZINC: ZINC000013513371
PDBe Ligand: ASG

PDB Entries

1c4s / 1dbo / 1dqo / 1hm2 / 1hmu / 1hmw / 1ofl / 1ofm / 1ojo / 1rwf …

Clinical Trials

Clinical Trials

Phase	Status	Purpose	Conditions	Count

Pharmacoeconomics

Manufacturers: Not Available
Packagers: Not Available
Dosage Forms: Not Available
Prices: Not Available
Patents: Not Available

Properties

State

Solid

Experimental Properties

Not Available

Predicted Properties

Property	Value	Source
Water Solubility	42.9 mg/mL	ALOGPS
logP	-2	ALOGPS
logP	-5	ChemAxon
logS	-0.85	ALOGPS
pKa (Strongest Acidic)	-1.9	ChemAxon
pKa (Strongest Basic)	-0.75	ChemAxon
Physiological Charge	-1	ChemAxon
Hydrogen Acceptor Count	8	ChemAxon
Hydrogen Donor Count	5	ChemAxon
Polar Surface Area	162.62 Å²	ChemAxon
Rotatable Bond Count	4	ChemAxon
Refractivity	57.02 m³·mol^-1	ChemAxon
Polarizability	26.15 Å³	ChemAxon
Number of Rings	1	ChemAxon
Bioavailability	1	ChemAxon
Rule of Five	Yes	ChemAxon
Ghose Filter	No	ChemAxon
Veber's Rule	No	ChemAxon
MDDR-like Rule	No	ChemAxon

Predicted ADMET Features

Not Available

Spectra

Mass Spec (NIST)

Not Available

Spectra

Spectrum	Spectrum Type	Splash Key
Predicted GC-MS Spectrum - GC-MS	Predicted GC-MS	Not Available
MS/MS Spectrum - Quattro_QQQ 10V, Positive	LC-MS/MS	splash10-0fk9-0190000000-9873b0cf34b6a2d02305
MS/MS Spectrum - Quattro_QQQ 25V, Positive	LC-MS/MS	splash10-0059-5900000000-0a0f78bfc09ede96dc12
MS/MS Spectrum - Quattro_QQQ 40V, Positive	LC-MS/MS	splash10-001i-9100000000-4309fcbb832ee8f8fe9d
Predicted MS/MS Spectrum - 10V, Positive (Annotated)	Predicted LC-MS/MS	Not Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)	Predicted LC-MS/MS	Not Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)	Predicted LC-MS/MS	Not Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)	Predicted LC-MS/MS	Not Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)	Predicted LC-MS/MS	Not Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)	Predicted LC-MS/MS	Not Available
1H NMR Spectrum	1D NMR	Not Applicable
[1H,13C] 2D NMR Spectrum	2D NMR	Not Applicable

Targets

Drugtargets

Accelerate your drug discovery research

with our fully connected ADMET & drug target dataset.

Accelerate your drug discovery research with our ADMET & drug target dataset

Details1. Chondroitinase (Chondroitin lyase)

Kind: Protein
Organism: Arthrobacter aurescens
Pharmacological action: Unknown

General Function: Carbon-oxygen lyase activity, acting on polysaccharides
Specific Function: Not Available
Gene Name: Not Available
Uniprot ID: P84141
Uniprot Name: Chondroitinase (Chondroitin lyase)
Molecular Weight: 79927.28 Da

Details2. Chondroitinase-B

Kind: Protein
Organism: Pedobacter heparinus (strain ATCC 13125 / DSM 2366 / NCIB 9290)
Pharmacological action: Unknown

General Function: Chondroitin b lyase activity
Specific Function: Cleaves the glycosaminoglycan, dermatan sulfate.
Gene Name: cslB
Uniprot ID: Q46079
Uniprot Name: Chondroitinase-B
Molecular Weight: 56336.075 Da

References

Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Details3. Hyaluronate lyase

Kind: Protein
Organism: Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)
Pharmacological action: Unknown

General Function: Hyaluronate lyase activity
Specific Function: Not Available
Gene Name: Not Available
Uniprot ID: Q54873
Uniprot Name: Hyaluronate lyase
Molecular Weight: 120770.645 Da

References

Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Details4. Chondroitinase-AC

Kind: Protein
Organism: Pedobacter heparinus (strain ATCC 13125 / DSM 2366 / NCIB 9290)
Pharmacological action: Unknown

General Function: Metal ion binding
Specific Function: Not Available
Gene Name: cslA
Uniprot ID: Q59288
Uniprot Name: Chondroitinase-AC
Molecular Weight: 79693.285 Da

References

Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created on June 13, 2005 13:24 / Updated on June 12, 2020 16:52